ReviewBiomedicines2024

Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials.

Hazem Ayesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.